New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations ...

Long-term data confirms early rituximab significantly delays new treatment for advanced, asymptomatic, low-burden follicular ...

Patients with follicular lymphoma, a slow-growing common type of non-Hodgkin's lymphoma, who are given 2 years of rituximab-maintenance therapy after immunochemotherapy, have significantly better ...

Rituximab Maintenance Therapy Improves Survival In Patients With Relapsed Follicular Lymphoma Date: February 10, 2009 Source: Journal of the National Cancer Institute Summary: Patients with ...

"As when initially reported, the totality of these data continue to support a retreatment strategy rather than maintenance rituximab when treating low tumor burden follicular lymphoma with ...

"We believe the retreatment strategy is the preferred option to help patients with low-tumor-burden follicular ... study showed that maintenance therapy with rituximab was superior to observation ...

low tumor burden follicular lymphoma can substantially delay the need for further treatment. At nearly 15 years of follow-up, 65% of those assigned to rituximab maintenance and 48% of those given ...

Therefore, the Committee considered that rituximab maintenance therapy should be recommended as an option for the treatment of people with follicular non-Hodgkin's lymphoma that has responded to first ...

Therefore, the Committee considered that rituximab maintenance therapy should be recommended as an option for the treatment of people with follicular non-Hodgkin's lymphoma that has responded to first ...